跳至主要内容
临床试验/ISRCTN18304314
ISRCTN18304314已完成未知

Mortality reduction in ICU-admitted COVID-19 patients in Suriname after treatment withconvalescent plasma acquired via gravity filtration

Academic Hospital Paramaribo0 个研究点目标入组 78 人开始时间: 2021年4月13日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
78

研究概览

简要总结

2023 Results article in https://doi.org/10.1128/mbio.03379-22 (added 12/06/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Polymerase chain reaction (PCR) confirmed COVID-19 disease
  • 2. Aged >18 years
  • 3. Written informed consent to participate in the study from the patient, or legal patient representative if the patient is unconscious (spouse or 1st-degree family member, and if absent 2nd-degree family member or acquaintance)
  • 4. Admittance to the ICU due to progressive respiratory failure ranging between severe and life-threatening ARDS based on the Berlin classification
  • 5. Requiring non-invasive ventilation

排除标准

  • 1. Requiring invasive ventilation
  • 2. A no ICU admission” or no invasive ventilation” restriction in place at the time of screening for the study
  • 3. Admitted to the COVID-19 ward but asymptomatic, admitted due to the national admission policy, or mild SARS-CoV2

研究者

发起方
Academic Hospital Paramaribo

相似试验